HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday, 13 February 2013

US Guidelines updated

In January, the AMCP published Version 3.1 of its Format For Formulary Submissions.  From the website:

“THE ROLE OF THE AMCP FORMAT: The evidence requirements contained herein are intended for use by manufacturers of pharmaceuticals, biologics and vaccines who are responding to an unsolicited request from a healthcare system to support reimbursement and/or formulary placement consideration of a new product, new indication, or new formulation of an existing product.”

A summary of changes is also available on the website; none relate to the methods of economic evaluation as described in Section 4.2 of the Format.